Foeldvari, I, Klotsche, J, Torok, KS, Kasapcopur, O, Adrovic, A, Feldman, B, Sztajnbok, F, Terreri, MT, Sakamoto, AP, Johnson, S, Anton, J, Khubchandani, R
, Stanevicha, V, Baykal, GÖ, Schonenberg‐Meinema, D, Alexeeva, E, Katsikas, M, Sawhney, S, Smith, V, Abu Al Saoud, S, Al-Abadi, E, Appenzeller, S, Avcin, T, Hajek, S, Hetlevik, SO, Kostik, M, Lehman, TJA, Li, S, Malcova, H, Marrani, E, Patwardhan, A, Sifuentes‐Giraldo, WA, Vasquez‐Canizares, N, Cabrera , N, Costa-Reis, P, Janarthanan, M, Nemcova, D, Pain, C, Santos, MJ, Battagliotti, C, Berntson, L, Bica, B, Brunner, J, Harel, L, Horneff, G, Kaiser, D, Kallinich, T, Lazarevic, D, López Benítez, JM, Minden, K, Moll, M, Nielsen, S, Nuruzzaman, F, Sparchez, Z, Uziel, Y & Helmus, N 2025, '
Is anti-SCL70 positivity associated with a more severe disease in juvenile systemic scleroderma?',
Pediatric Rheumatology, vol. 23, no. Suppl.2, P170, pp. 127.